CKD 5
The percentage of patients on the CKD register with hypertension and proteinuria who are treated with an angiotensin coverting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (AEB) (unless a contraindication or side effects are recorded)
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| CKD 5 | 2011 | 218 | 243 | 89.7% | |
| CKD 5 | 2012 | 279 | 325 | 85.9% | |
| CKD 5 | 2013 | 299 | 351 | 85.2% | |
| CKD003 | 2014 | 319 | 351 | 90.9% | |
| CKD003 | 2015 | 357 | 412 | 86.7% | |
| NM84 | 2016 | 344 | 512 | 67.2% | |
| NM84 | 2017 | 361 | 575 | 62.8% | |
| NM84 | 2018 | 341 | 564 | 60.5% | |
| NM84 | 2019 | 243 | 421 | 57.7% |
